JY
PTX

Jeff Yass’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Jeff Yass’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,600
Closed -$31K – 10923
2018
Q2 		$31K Buy
+12,600
New +$30.9K ﹤0.01% 9370
2017
Q4 		– Sell
-42,200
Closed -$133K – 10436
2017
Q3 		$133K Sell
42,200
-204,900
-83% -$658K ﹤0.01% 8256
2017
Q2 		$993K Buy
247,100
+42,000
+20% +$183K ﹤0.01% 5276
2017
Q1 		$759K Buy
+205,100
New +$644K ﹤0.01% 5710
2015
Q2 		– Sell
-5,030
Closed -$538K – 10727
2015
Q1 		$538K Sell
5,030
-830
-14% -$79.1K ﹤0.01% 6963
2014
Q4 		$550K Sell
5,860
-730
-11% -$69.6K ﹤0.01% 7032
2014
Q3 		$506K Buy
6,590
+5,050
+328% +$398K ﹤0.01% 7190
2014
Q2 		$138K Buy
+1,540
New +$94.4K ﹤0.01% 9290

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
MFGP
Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jeff Yass's PTX Position: Q2 2018 in Review

Jeff Yass sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2018, closing a stake of 15,124 shares — an estimated $37K sold.

Jeff Yass first reported a position in PTX in Q2 2014 and held it in 10 quarters. The position peaked at $854K in Q2 2014. 29 funds tracked by Wall St. Rank hold PTX as of Q2 2018.

  • Jeff Yass reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
  • Jeff Yass sold 15,124 Pernix Therapeutics Holdings, Inc. shares in Q2 2018, an estimated $37K.
  • Jeff Yass first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 10 quarters.
  • Jeff Yass's Pernix Therapeutics Holdings, Inc. position peaked at $854K in Q2 2014.
  • 29 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2018.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.